Home | Body & Mind/Health

The Promise of Low Dose Naltrexone Therapy
Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
Elaine A. Moore and Samantha Wilkinson
Foreword by Yash Pal Agrawal, M.D., Ph.D.

ISBN 978-0-7864-3715-3
21 photos, glossary, appendix, notes, bibliography, index
223pp. softcover 2009

Description
Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn’s disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.

About the Author
Elaine A. Moore has worked in hospital laboratories for more than 30 years, primarily in immunohematology and toxicology. She is a freelance medical writer and laboratory consultant. For more information, visit her website at www.elaine-moore.com. She lives in Sedalia, Colorado.

Other Book(s) by Elaine A. Moore Available from McFarland:

Graves’ Disease

Autoimmune Diseases and Their Environmental Triggers

Encyclopedia of Alzheimer’s Disease; With Directories of Research, Treatment and Care Facilities

Hepatitis

Encyclopedia of Sexually Transmitted Diseases



Table of Contents & Excerpts

Related Books
Body & Mind/Health